Intellia Therapeutics
- In Vitro and In Vivo Diagnostic Substances
- Cambridge, Massachusetts
Compensation history
Top executives at Intellia Therapeutics received an average of $3M per person in annual compensation from 2015 to 2021.
Average pay of disclosed executives at Intellia Therapeutics
By year
- 2021
JB$15MJames BastaExecutive Vice President, General Counsel and Corporate SecretaryJL$10MJohn M. LeonardPresident, Chief Executive OfficerLS$5MLaura Sepp-LorenzinoExecutive Vice President, Chief Scientific OfficerDL$4MDavid LebwohlExecutive Vice President, Chief Medical OfficerGG$4MGlenn G. GoddardExecutive Vice President, Chief Financial Officer and Treasurer- 2019
LS$2MLaura Sepp-LorenzinoExecutive Vice President, Chief Scientific OfficerAS$1MAndrew D. SchiermeierExecutive Vice President, Chief Operating OfficerJL$904KJohn M. LeonardPresident, Chief Executive OfficerJR$638KJosé E. RiveraExecutive Vice President, General CounselGG$542KGlenn G. GoddardExecutive Vice President, Chief Financial Officer
Executives
We found nine executives who work or worked at Intellia Therapeutics.
John Leonard
Intellia Therapeutics
Chief Executive Officer
Glenn Goddard
Intellia Therapeutics
Chief Financial Officer
James Basta
Intellia Therapeutics
General Counsel
David Lebwohl
Intellia Therapeutics
Chief Medical Officer
Laura Sepp-Lorenzino
Intellia Therapeutics
Chief Scientific Officer
José Rivera
Intellia Therapeutics
General Counsel
Andrew Schiermeier
Intellia Therapeutics
Chief Operating Officer
Graeme Bell
Intellia Therapeutics
Chief Financial Officer
News
About Intellia Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryIn Vitro and In Vivo Diagnostic Substances
- Address40 Erie Street, Suite 130, Cambridge, Massachusetts 02139
- Phone857-285-6200
- Fiscal year endDecember 31
Source: SEC filings on May 2, 2022, April 24, 2020, April 16, 2019, April 17, 2018, and April 18, 2017.